Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients.

Abstract
Authors	Kadri Altundag
Journal	Journal of B.U.ON. : official journal of the Balkan Union of Oncology (J BUON) 2018 Sep-Oct Vol. 23 Issue 5 Pg. 1559-1560 ISSN: 1107-0625 [Print] Cyprus
PMID	30570888 (Publication Type: Letter)
Chemical References	Aromatase Inhibitors Receptors, Cell Surface
Topics	Antineoplastic Combined Chemotherapy Protocols (therapeutic use) Aromatase Inhibitors (administration & dosage) Breast Neoplasms (drug therapy, metabolism, pathology) Chemotherapy, Adjuvant Female Humans Randomized Controlled Trials as Topic Receptors, Cell Surface (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!